Opus Genetics (IRD) Tax Rate (2022 - 2025)

Opus Genetics (IRD) posted quarterly Tax Rate of 63.03% for Q4 2025, up 151070.97% quarter-over-quarter from 0.04% in Q4 2023.

Opus Genetics (IRD) Tax Rate (2022 - 2025) Analysis & Trends

Opus Genetics (IRD) has reported Tax Rate for 3 consecutive years, with 63.03% the latest figure, recorded in Q4 2025.

In Q4 2025, Tax Rate changed N/A year-over-year to 63.03%; the TTM figure through Mar 2026 stood at 9.74% (changed N/A YoY), while the FY2025 annual figure was 21.0%, changed N/A from the prior year.
Tax Rate rose to 63.03% in Q4 2025 per IRD's latest filing, from 0.04% in the prior quarter.
Across five years, Tax Rate topped out at 63.03% in Q4 2025 and bottomed at 0.04% in Q4 2023.
Historically, Tax Rate has averaged 16.06% across 3 years, with a median of 0.59% in 2023.
On a YoY basis, Tax Rate climbed as much as 88 bps in 2023 and fell as far as 88 bps in 2023.
Opus Genetics' Tax Rate stood at 0.92% in 2022, then tumbled by 95 bps to 0.04% in 2023, then surged by 151071 bps to 63.03% in 2025.
Business Quant data shows IRD's Tax Rate at 63.03% in Q4 2025, 0.04% in Q4 2023, and 0.25% in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	Opus Genetics	298.36 Mn	209.55 Mn	-	-

Download Data